Joint Lp-Norm and L2,1-Norm Constrained Graph Laplacian PCA for Robust Tumor Sample Clustering and Gene Network Module Discovery

The dimensionality reduction method accompanied by different norm constraints plays an important role in mining useful information from large-scale gene expression data. In this article, a novel method named Lp-norm and L-2,L-1-norm constrained graph Laplacian principal component analysis (PL21GPCA) based on traditional principal component analysis (PCA) is proposed for robust tumor sample clustering and gene network module discovery. Three aspects are highlighted in the PL21GPCA method. First, to degrade the high sensitivity to outliers and noise, the non-convex proximal Lp-norm (0 < p < 1)constraint is applied on the loss function. Second, to enhance the sparsity of gene expression in cancer samples, the L-2,(1)-norm constraint is used on one of the regularization terms. Third, to retain the geometric structure of the data, we introduce the graph Laplacian regularization item to the PL21GPCA optimization model. Extensive experiments on five gene expression datasets, including one benchmark dataset, two single-cancer datasets from The Cancer Genome Atlas (TCGA), and two integrated datasets of multiple cancers from TCGA, are performed to validate the effectiveness of our method. The experimental results demonstrate that the PL21GPCA method performs better than many other methods in terms of tumor sample clustering. Additionally, this method is used to discover the gene network modules for the purpose of finding key genes that may be associated with some cancers.

Automated summary

The novel dimensionality reduction method PL21GPCA proposed in this article plays a crucial role in mining useful information from large-scale gene expression data. By applying different norm constraints, the method ensures robustness against outliers and noise, as well as enhances the sparsity of gene expression. Experimental results demonstrate the superior performance of the method in tumor sample clustering and gene network module discovery.